Intravesical instillation of epirubicin combined with BCG to prevent the recurrence of bladder cancer after surgical management
- VernacularTitle:表阿霉素加卡介苗膀胱灌注预防膀胱癌术后复发的疗效观察
- Author:
Xiangbo ZHANG
;
Zhiping WANG
;
Jianmin DUAN
- Publication Type:Journal Article
- Keywords:
Bladder neoplasms;
Carcinoma;
Epirubicin;
BCG;
Perfusion
- From:
Chinese Journal of Urology
2001;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate intravesical instillation of epirubicin plus BCG to prevent recurrence of transitional cell cancer of bladder after surgical management. Methods A total of 44 cases of bladder cancer who underwent TURBT or partial cystectomy were divided into 2 groups.①Group 1 received intravesical instillation of epirubicin plus BCG (24 cases).Within 1 week following operation single dose of intravesical epirubicin instillation was given and from the second week regular intravesical BCG was instilled afterwards.②Group 2 received BCG alone (20 cases).Within 1 week after surgical management regular intravesical BCG instillation was given. All the patients were followed up for 24 months. Results In Group 2,3 cases had recurrence at 5,9,12 months individually,the incidence rate being 15% (3/20).No recurrence developed in Group 1.The recurrence rate was significantly different between the 2 groups (?2 test,P
